The ongoing battle on the issue of abortion has ramped up in recent months. The abortion pill, mifepristone, has come under intense controversy from both sides of the aisle. Otherwise known as “The Pill,” the drug has been the topic of much scrutiny due to its adverse side effects and an allegation that the Food and Drug Administration rushed its approval amidst lobbying from pharmaceuticals. On April 7, District Court Judge Matthew J. Kacsmaryk, who hears cases in Amarillo at the North Texas U.S. District Court, ruled to overturn the Food and Drug Administration’s approval of mifepristone. He argued the approval was rushed, which led to an unsafe drug being offered in the market. At the same time, a federal judge in the Washington District Court ruled that there would be no changes that ...